- Telehealth Visits
- Insurance plan information
Brianna M. Paul, PhD
Neuropsychology- Telehealth Visits
- Insurance plan information
Brianna M. Paul, PhD
Neuropsychology- Telehealth Visits
- Insurance plan information
On this page
About me
Brianna Paul is a neuropsychologist and licensed clinical psychologist at the UCSF Pediatric Epilepsy Center, where she specializes in evaluating children with medically refractory epilepsy, or epilepsy that is difficult to control with medication. She also has expertise in evaluating pediatric disorders such as learning disabilities, autism spectrum disorders and attention-deficit/hyperactivity disorder.
In her research, Paul has used cognitive-behavioral and neuroimaging methods to investigate brain and cognitive development in patients with epilepsy, Williams syndrome and early brain injury due to stroke.
Paul earned her bachelor's degree in biochemistry and psychology at the University of Arizona. She earned a doctorate in clinical psychology, specializing in neuropsychology, in a joint doctoral program of San Diego State University and the University of California, San Diego. She completed an internship as well as a fellowship in neuropsychology at UCLA. She joined UCSF in 2009.
Education & training
Fellowship
- Neuropsychology, University of California Los Angeles
Internship
- Neuropsychology, University of California Los Angeles
Degree
- PHD, San Diego State University
My expertise
Specialties
- Neuropsychology
Clinical Trials query: q=health_gateway_id_ss%3A%28%221684%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%221684%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.